Predictmedix Inc.
Predictmedix Inc. PMEDF Peers
See (PMEDF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PMEDF | $0.01 | N/A | 2.6M | -1.47 | -$0.01 | N/A |
| SMMNY | $26.55 | +2.15% | 119.1B | 24.81 | $1.07 | +0.96% |
| SEMHF | $54.75 | +2.84% | 61.4B | 25.58 | $2.14 | +2.09% |
| RYLPF | $23.21 | N/A | 22B | 77.38 | $0.30 | +4.09% |
| SONVF | $297.98 | -4.41% | 17.8B | 27.01 | $11.03 | +1.76% |
| SONVY | $59.32 | -1.71% | 17.7B | 26.84 | $2.21 | +1.27% |
| SNNUF | $14.53 | N/A | 12.7B | 30.91 | $0.47 | +2.58% |
| CHEOY | $92.76 | +0.41% | 12.1B | 50.14 | $1.85 | +1.46% |
| CHEOF | $181.00 | N/A | 11.8B | 49.18 | $3.68 | +1.53% |
| WILYY | $21.31 | N/A | 9.1B | 20.69 | $1.03 | N/A |
Stock Comparison
PMEDF vs SMMNY Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, SMMNY has a market cap of 119.1B. Regarding current trading prices, PMEDF is priced at $0.01, while SMMNY trades at $26.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas SMMNY's P/E ratio is 24.81. In terms of profitability, PMEDF's ROE is +1.68%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, PMEDF is less volatile compared to SMMNY. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs SEMHF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, SEMHF has a market cap of 61.4B. Regarding current trading prices, PMEDF is priced at $0.01, while SEMHF trades at $54.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas SEMHF's P/E ratio is 25.58. In terms of profitability, PMEDF's ROE is +1.68%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, PMEDF is less volatile compared to SEMHF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs RYLPF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, RYLPF has a market cap of 22B. Regarding current trading prices, PMEDF is priced at $0.01, while RYLPF trades at $23.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas RYLPF's P/E ratio is 77.38. In terms of profitability, PMEDF's ROE is +1.68%, compared to RYLPF's ROE of +0.03%. Regarding short-term risk, PMEDF is less volatile compared to RYLPF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs SONVF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, SONVF has a market cap of 17.8B. Regarding current trading prices, PMEDF is priced at $0.01, while SONVF trades at $297.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas SONVF's P/E ratio is 27.01. In terms of profitability, PMEDF's ROE is +1.68%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, PMEDF is less volatile compared to SONVF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs SONVY Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, SONVY has a market cap of 17.7B. Regarding current trading prices, PMEDF is priced at $0.01, while SONVY trades at $59.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas SONVY's P/E ratio is 26.84. In terms of profitability, PMEDF's ROE is +1.68%, compared to SONVY's ROE of +0.21%. Regarding short-term risk, PMEDF is less volatile compared to SONVY. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs SNNUF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, SNNUF has a market cap of 12.7B. Regarding current trading prices, PMEDF is priced at $0.01, while SNNUF trades at $14.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas SNNUF's P/E ratio is 30.91. In terms of profitability, PMEDF's ROE is +1.68%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, PMEDF is less volatile compared to SNNUF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs CHEOY Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, CHEOY has a market cap of 12.1B. Regarding current trading prices, PMEDF is priced at $0.01, while CHEOY trades at $92.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas CHEOY's P/E ratio is 50.14. In terms of profitability, PMEDF's ROE is +1.68%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, PMEDF is less volatile compared to CHEOY. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs CHEOF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, CHEOF has a market cap of 11.8B. Regarding current trading prices, PMEDF is priced at $0.01, while CHEOF trades at $181.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas CHEOF's P/E ratio is 49.18. In terms of profitability, PMEDF's ROE is +1.68%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, PMEDF is less volatile compared to CHEOF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs WILYY Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, WILYY has a market cap of 9.1B. Regarding current trading prices, PMEDF is priced at $0.01, while WILYY trades at $21.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas WILYY's P/E ratio is 20.69. In terms of profitability, PMEDF's ROE is +1.68%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, PMEDF is less volatile compared to WILYY. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs WILLF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, WILLF has a market cap of 8.5B. Regarding current trading prices, PMEDF is priced at $0.01, while WILLF trades at $41.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas WILLF's P/E ratio is 20.09. In terms of profitability, PMEDF's ROE is +1.68%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, PMEDF is less volatile compared to WILLF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs GNGBF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, GNGBF has a market cap of 5.4B. Regarding current trading prices, PMEDF is priced at $0.01, while GNGBF trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas GNGBF's P/E ratio is 37.04. In terms of profitability, PMEDF's ROE is +1.68%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, PMEDF is less volatile compared to GNGBF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs GNGBY Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, GNGBY has a market cap of 5.2B. Regarding current trading prices, PMEDF is priced at $0.01, while GNGBY trades at $18.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas GNGBY's P/E ratio is 33.04. In terms of profitability, PMEDF's ROE is +1.68%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, PMEDF is less volatile compared to GNGBY. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs NHNKY Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, NHNKY has a market cap of 4.3B. Regarding current trading prices, PMEDF is priced at $0.01, while NHNKY trades at $13.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas NHNKY's P/E ratio is 22.46. In terms of profitability, PMEDF's ROE is +1.68%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, PMEDF and NHNKY have similar daily volatility (0.00).
PMEDF vs AMBFF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, AMBFF has a market cap of 4B. Regarding current trading prices, PMEDF is priced at $0.01, while AMBFF trades at $15.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas AMBFF's P/E ratio is 72.21. In terms of profitability, PMEDF's ROE is +1.68%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, PMEDF is less volatile compared to AMBFF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs AMBBY Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, AMBBY has a market cap of 4B. Regarding current trading prices, PMEDF is priced at $0.01, while AMBBY trades at $14.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas AMBBY's P/E ratio is 70.19. In terms of profitability, PMEDF's ROE is +1.68%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, PMEDF is less volatile compared to AMBBY. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs NHNKF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, NHNKF has a market cap of 2.5B. Regarding current trading prices, PMEDF is priced at $0.01, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, PMEDF's ROE is +1.68%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, PMEDF and NHNKF have similar daily volatility (0.00).
PMEDF vs GNNDY Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, GNNDY has a market cap of 2.2B. Regarding current trading prices, PMEDF is priced at $0.01, while GNNDY trades at $45.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas GNNDY's P/E ratio is 17.64. In terms of profitability, PMEDF's ROE is +1.68%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, PMEDF is less volatile compared to GNNDY. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs GGNDF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, GGNDF has a market cap of 2.1B. Regarding current trading prices, PMEDF is priced at $0.01, while GGNDF trades at $14.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas GGNDF's P/E ratio is 16.72. In terms of profitability, PMEDF's ROE is +1.68%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, PMEDF is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs STSEY Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, STSEY has a market cap of 2B. Regarding current trading prices, PMEDF is priced at $0.01, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas STSEY's P/E ratio is 39.41. In terms of profitability, PMEDF's ROE is +1.68%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, PMEDF and STSEY have similar daily volatility (0.00).
PMEDF vs VTRLY Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, VTRLY has a market cap of 2B. Regarding current trading prices, PMEDF is priced at $0.01, while VTRLY trades at $14.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas VTRLY's P/E ratio is 37.49. In terms of profitability, PMEDF's ROE is +1.68%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, PMEDF is less volatile compared to VTRLY. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs MCRPF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, MCRPF has a market cap of 1.9B. Regarding current trading prices, PMEDF is priced at $0.01, while MCRPF trades at $1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas MCRPF's P/E ratio is -8.67. In terms of profitability, PMEDF's ROE is +1.68%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, PMEDF is less volatile compared to MCRPF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs OSSFF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, OSSFF has a market cap of 1.8B. Regarding current trading prices, PMEDF is priced at $0.01, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, PMEDF's ROE is +1.68%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, PMEDF is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs DWRKF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, DWRKF has a market cap of 1.8B. Regarding current trading prices, PMEDF is priced at $0.01, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, PMEDF's ROE is +1.68%, compared to DWRKF's ROE of N/A. Regarding short-term risk, PMEDF and DWRKF have similar daily volatility (0.00).
PMEDF vs OSSUY Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, OSSUY has a market cap of 1.7B. Regarding current trading prices, PMEDF is priced at $0.01, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, PMEDF's ROE is +1.68%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, PMEDF and OSSUY have similar daily volatility (0.00).
PMEDF vs MEDGF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, MEDGF has a market cap of 1.7B. Regarding current trading prices, PMEDF is priced at $0.01, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, PMEDF's ROE is +1.68%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, PMEDF and MEDGF have similar daily volatility (0.00).
PMEDF vs DRWKF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, DRWKF has a market cap of 1.4B. Regarding current trading prices, PMEDF is priced at $0.01, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas DRWKF's P/E ratio is 9.56. In terms of profitability, PMEDF's ROE is +1.68%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, PMEDF is less volatile compared to DRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs DGWPF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, DGWPF has a market cap of 1.2B. Regarding current trading prices, PMEDF is priced at $0.01, while DGWPF trades at $57.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas DGWPF's P/E ratio is 8.06. In terms of profitability, PMEDF's ROE is +1.68%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, PMEDF is less volatile compared to DGWPF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs XVIPF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, XVIPF has a market cap of 1B. Regarding current trading prices, PMEDF is priced at $0.01, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas XVIPF's P/E ratio is 71.52. In terms of profitability, PMEDF's ROE is +1.68%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, PMEDF and XVIPF have similar daily volatility (0.00).
PMEDF vs LFTSF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, LFTSF has a market cap of 1B. Regarding current trading prices, PMEDF is priced at $0.01, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, PMEDF's ROE is +1.68%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, PMEDF and LFTSF have similar daily volatility (0.00).
PMEDF vs ELEAF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, ELEAF has a market cap of 832.7M. Regarding current trading prices, PMEDF is priced at $0.01, while ELEAF trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas ELEAF's P/E ratio is 11.81. In terms of profitability, PMEDF's ROE is +1.68%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, PMEDF is less volatile compared to ELEAF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs MDRSF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, MDRSF has a market cap of 828.1M. Regarding current trading prices, PMEDF is priced at $0.01, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, PMEDF's ROE is +1.68%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, PMEDF is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs CALZF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, CALZF has a market cap of 552.7M. Regarding current trading prices, PMEDF is priced at $0.01, while CALZF trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas CALZF's P/E ratio is 80.00. In terms of profitability, PMEDF's ROE is +1.68%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, PMEDF is less volatile compared to CALZF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs AVMR Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, AVMR has a market cap of 494.2M. Regarding current trading prices, PMEDF is priced at $0.01, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas AVMR's P/E ratio is -18.34. In terms of profitability, PMEDF's ROE is +1.68%, compared to AVMR's ROE of -1.38%. Regarding short-term risk, PMEDF and AVMR have similar daily volatility (0.00).
PMEDF vs CLVSF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, CLVSF has a market cap of 459.8M. Regarding current trading prices, PMEDF is priced at $0.01, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, PMEDF's ROE is +1.68%, compared to CLVSF's ROE of +0.19%. Regarding short-term risk, PMEDF is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs IOBCF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, IOBCF has a market cap of 393M. Regarding current trading prices, PMEDF is priced at $0.01, while IOBCF trades at $13.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas IOBCF's P/E ratio is 37.26. In terms of profitability, PMEDF's ROE is +1.68%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, PMEDF and IOBCF have similar daily volatility (0.00).
PMEDF vs CSSPF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, CSSPF has a market cap of 384M. Regarding current trading prices, PMEDF is priced at $0.01, while CSSPF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas CSSPF's P/E ratio is 92.00. In terms of profitability, PMEDF's ROE is +1.68%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, PMEDF is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs HYBT Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, HYBT has a market cap of 361.4M. Regarding current trading prices, PMEDF is priced at $0.01, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas HYBT's P/E ratio is N/A. In terms of profitability, PMEDF's ROE is +1.68%, compared to HYBT's ROE of -0.00%. Regarding short-term risk, PMEDF and HYBT have similar daily volatility (0.00).
PMEDF vs EAPIF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, EAPIF has a market cap of 295.2M. Regarding current trading prices, PMEDF is priced at $0.01, while EAPIF trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas EAPIF's P/E ratio is -1.95. In terms of profitability, PMEDF's ROE is +1.68%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, PMEDF is less volatile compared to EAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs CYBQY Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, CYBQY has a market cap of 253.5M. Regarding current trading prices, PMEDF is priced at $0.01, while CYBQY trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas CYBQY's P/E ratio is -60.00. In terms of profitability, PMEDF's ROE is +1.68%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, PMEDF is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs HTLZF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, HTLZF has a market cap of 245.1M. Regarding current trading prices, PMEDF is priced at $0.01, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, PMEDF's ROE is +1.68%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, PMEDF and HTLZF have similar daily volatility (0.00).
PMEDF vs CLLKF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, CLLKF has a market cap of 241.5M. Regarding current trading prices, PMEDF is priced at $0.01, while CLLKF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas CLLKF's P/E ratio is -7.77. In terms of profitability, PMEDF's ROE is +1.68%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, PMEDF and CLLKF have similar daily volatility (0.00).
PMEDF vs BCCOY Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, BCCOY has a market cap of 221M. Regarding current trading prices, PMEDF is priced at $0.01, while BCCOY trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas BCCOY's P/E ratio is -7.27. In terms of profitability, PMEDF's ROE is +1.68%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, PMEDF is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs IMPZY Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, IMPZY has a market cap of 199.9M. Regarding current trading prices, PMEDF is priced at $0.01, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, PMEDF's ROE is +1.68%, compared to IMPZY's ROE of -2.86%. Regarding short-term risk, PMEDF and IMPZY have similar daily volatility (0.00).
PMEDF vs DTXMF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, DTXMF has a market cap of 180.6M. Regarding current trading prices, PMEDF is priced at $0.01, while DTXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas DTXMF's P/E ratio is -9.52. In terms of profitability, PMEDF's ROE is +1.68%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, PMEDF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs CYBQF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, CYBQF has a market cap of 162.8M. Regarding current trading prices, PMEDF is priced at $0.01, while CYBQF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas CYBQF's P/E ratio is -61.00. In terms of profitability, PMEDF's ROE is +1.68%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, PMEDF is less volatile compared to CYBQF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs DMTRF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, DMTRF has a market cap of 161.3M. Regarding current trading prices, PMEDF is priced at $0.01, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, PMEDF's ROE is +1.68%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, PMEDF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs PXMBF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, PXMBF has a market cap of 154.5M. Regarding current trading prices, PMEDF is priced at $0.01, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, PMEDF's ROE is +1.68%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, PMEDF and PXMBF have similar daily volatility (0.00).
PMEDF vs EKDHF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, EKDHF has a market cap of 142.6M. Regarding current trading prices, PMEDF is priced at $0.01, while EKDHF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas EKDHF's P/E ratio is 15.88. In terms of profitability, PMEDF's ROE is +1.68%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, PMEDF is less volatile compared to EKDHF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs AVHHL Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, AVHHL has a market cap of 138.8M. Regarding current trading prices, PMEDF is priced at $0.01, while AVHHL trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas AVHHL's P/E ratio is -2.20. In terms of profitability, PMEDF's ROE is +1.68%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, PMEDF is less volatile compared to AVHHL. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs BRSYF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, BRSYF has a market cap of 128.5M. Regarding current trading prices, PMEDF is priced at $0.01, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas BRSYF's P/E ratio is 30.91. In terms of profitability, PMEDF's ROE is +1.68%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, PMEDF is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs AMEUF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, AMEUF has a market cap of 120.5M. Regarding current trading prices, PMEDF is priced at $0.01, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, PMEDF's ROE is +1.68%, compared to AMEUF's ROE of -5.13%. Regarding short-term risk, PMEDF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs VMTHF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, VMTHF has a market cap of 110M. Regarding current trading prices, PMEDF is priced at $0.01, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas VMTHF's P/E ratio is -1.09. In terms of profitability, PMEDF's ROE is +1.68%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, PMEDF is less volatile compared to VMTHF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs FDMDF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, FDMDF has a market cap of 106.1M. Regarding current trading prices, PMEDF is priced at $0.01, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, PMEDF's ROE is +1.68%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, PMEDF and FDMDF have similar daily volatility (0.00).
PMEDF vs JMDMF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, JMDMF has a market cap of 100.6M. Regarding current trading prices, PMEDF is priced at $0.01, while JMDMF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas JMDMF's P/E ratio is -27.83. In terms of profitability, PMEDF's ROE is +1.68%, compared to JMDMF's ROE of N/A. Regarding short-term risk, PMEDF is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs RSHUF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, RSHUF has a market cap of 91.5M. Regarding current trading prices, PMEDF is priced at $0.01, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, PMEDF's ROE is +1.68%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, PMEDF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs SOMNF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, SOMNF has a market cap of 90.8M. Regarding current trading prices, PMEDF is priced at $0.01, while SOMNF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas SOMNF's P/E ratio is -14.00. In terms of profitability, PMEDF's ROE is +1.68%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, PMEDF is less volatile compared to SOMNF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs CKMTF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, CKMTF has a market cap of 85.2M. Regarding current trading prices, PMEDF is priced at $0.01, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, PMEDF's ROE is +1.68%, compared to CKMTF's ROE of +2.58%. Regarding short-term risk, PMEDF and CKMTF have similar daily volatility (0.00).
PMEDF vs SNZZF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, SNZZF has a market cap of 68.6M. Regarding current trading prices, PMEDF is priced at $0.01, while SNZZF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas SNZZF's P/E ratio is -4.68. In terms of profitability, PMEDF's ROE is +1.68%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, PMEDF is less volatile compared to SNZZF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs IPDQF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, IPDQF has a market cap of 64.1M. Regarding current trading prices, PMEDF is priced at $0.01, while IPDQF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas IPDQF's P/E ratio is -3.16. In terms of profitability, PMEDF's ROE is +1.68%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, PMEDF and IPDQF have similar daily volatility (0.00).
PMEDF vs RDGL Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, RDGL has a market cap of 54.9M. Regarding current trading prices, PMEDF is priced at $0.01, while RDGL trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas RDGL's P/E ratio is -12.10. In terms of profitability, PMEDF's ROE is +1.68%, compared to RDGL's ROE of -1.57%. Regarding short-term risk, PMEDF is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs BLOZF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, BLOZF has a market cap of 52.4M. Regarding current trading prices, PMEDF is priced at $0.01, while BLOZF trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas BLOZF's P/E ratio is -22.75. In terms of profitability, PMEDF's ROE is +1.68%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, PMEDF is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs BRNHF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, BRNHF has a market cap of 42.2M. Regarding current trading prices, PMEDF is priced at $0.01, while BRNHF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas BRNHF's P/E ratio is -1.33. In terms of profitability, PMEDF's ROE is +1.68%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, PMEDF and BRNHF have similar daily volatility (0.00).
PMEDF vs NVYTF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, NVYTF has a market cap of 38M. Regarding current trading prices, PMEDF is priced at $0.01, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas NVYTF's P/E ratio is -0.72. In terms of profitability, PMEDF's ROE is +1.68%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, PMEDF is less volatile compared to NVYTF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs TLTFF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, TLTFF has a market cap of 35.6M. Regarding current trading prices, PMEDF is priced at $0.01, while TLTFF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas TLTFF's P/E ratio is -14.20. In terms of profitability, PMEDF's ROE is +1.68%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, PMEDF is less volatile compared to TLTFF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs ELXMF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, ELXMF has a market cap of 28.4M. Regarding current trading prices, PMEDF is priced at $0.01, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, PMEDF's ROE is +1.68%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, PMEDF and ELXMF have similar daily volatility (0.00).
PMEDF vs KBBTF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, KBBTF has a market cap of 24.1M. Regarding current trading prices, PMEDF is priced at $0.01, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, PMEDF's ROE is +1.68%, compared to KBBTF's ROE of N/A. Regarding short-term risk, PMEDF and KBBTF have similar daily volatility (0.00).
PMEDF vs POSC Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, POSC has a market cap of 22.8M. Regarding current trading prices, PMEDF is priced at $0.01, while POSC trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas POSC's P/E ratio is 0.38. In terms of profitability, PMEDF's ROE is +1.68%, compared to POSC's ROE of +9.25%. Regarding short-term risk, PMEDF is less volatile compared to POSC. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs MDXHF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, MDXHF has a market cap of 20.5M. Regarding current trading prices, PMEDF is priced at $0.01, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, PMEDF's ROE is +1.68%, compared to MDXHF's ROE of +0.43%. Regarding short-term risk, PMEDF and MDXHF have similar daily volatility (0.00).
PMEDF vs EMITF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, EMITF has a market cap of 19.4M. Regarding current trading prices, PMEDF is priced at $0.01, while EMITF trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas EMITF's P/E ratio is -12.50. In terms of profitability, PMEDF's ROE is +1.68%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, PMEDF and EMITF have similar daily volatility (0.00).
PMEDF vs GTHP Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, GTHP has a market cap of 18.1M. Regarding current trading prices, PMEDF is priced at $0.01, while GTHP trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas GTHP's P/E ratio is -4.60. In terms of profitability, PMEDF's ROE is +1.68%, compared to GTHP's ROE of +0.78%. Regarding short-term risk, PMEDF and GTHP have similar daily volatility (0.00).
PMEDF vs PYNKF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, PYNKF has a market cap of 17.8M. Regarding current trading prices, PMEDF is priced at $0.01, while PYNKF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas PYNKF's P/E ratio is -0.91. In terms of profitability, PMEDF's ROE is +1.68%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, PMEDF is less volatile compared to PYNKF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs VPTDF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, VPTDF has a market cap of 17.6M. Regarding current trading prices, PMEDF is priced at $0.01, while VPTDF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas VPTDF's P/E ratio is -5.38. In terms of profitability, PMEDF's ROE is +1.68%, compared to VPTDF's ROE of +2.34%. Regarding short-term risk, PMEDF is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs DIZTF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, DIZTF has a market cap of 16.9M. Regarding current trading prices, PMEDF is priced at $0.01, while DIZTF trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas DIZTF's P/E ratio is -10.50. In terms of profitability, PMEDF's ROE is +1.68%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, PMEDF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs ASAPF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, ASAPF has a market cap of 16.8M. Regarding current trading prices, PMEDF is priced at $0.01, while ASAPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas ASAPF's P/E ratio is -21.50. In terms of profitability, PMEDF's ROE is +1.68%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, PMEDF and ASAPF have similar daily volatility (0.00).
PMEDF vs RMSL Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, RMSL has a market cap of 15M. Regarding current trading prices, PMEDF is priced at $0.01, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas RMSL's P/E ratio is 0.98. In terms of profitability, PMEDF's ROE is +1.68%, compared to RMSL's ROE of -2.03%. Regarding short-term risk, PMEDF is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs TMDIF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, TMDIF has a market cap of 13.9M. Regarding current trading prices, PMEDF is priced at $0.01, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, PMEDF's ROE is +1.68%, compared to TMDIF's ROE of -1.38%. Regarding short-term risk, PMEDF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs ALRTF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, ALRTF has a market cap of 13.3M. Regarding current trading prices, PMEDF is priced at $0.01, while ALRTF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas ALRTF's P/E ratio is -0.70. In terms of profitability, PMEDF's ROE is +1.68%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, PMEDF is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs PLLWF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, PLLWF has a market cap of 13.3M. Regarding current trading prices, PMEDF is priced at $0.01, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas PLLWF's P/E ratio is -1.10. In terms of profitability, PMEDF's ROE is +1.68%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, PMEDF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs IMEXF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, IMEXF has a market cap of 12M. Regarding current trading prices, PMEDF is priced at $0.01, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas IMEXF's P/E ratio is -0.17. In terms of profitability, PMEDF's ROE is +1.68%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, PMEDF is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs ATBPF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, ATBPF has a market cap of 11.4M. Regarding current trading prices, PMEDF is priced at $0.01, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, PMEDF's ROE is +1.68%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, PMEDF is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs LXXGF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, LXXGF has a market cap of 11.3M. Regarding current trading prices, PMEDF is priced at $0.01, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, PMEDF's ROE is +1.68%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, PMEDF and LXXGF have similar daily volatility (0.00).
PMEDF vs MKEAF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, MKEAF has a market cap of 10.7M. Regarding current trading prices, PMEDF is priced at $0.01, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, PMEDF's ROE is +1.68%, compared to MKEAF's ROE of +0.50%. Regarding short-term risk, PMEDF and MKEAF have similar daily volatility (0.00).
PMEDF vs NGMDF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, NGMDF has a market cap of 9.1M. Regarding current trading prices, PMEDF is priced at $0.01, while NGMDF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas NGMDF's P/E ratio is -4.00. In terms of profitability, PMEDF's ROE is +1.68%, compared to NGMDF's ROE of +1.10%. Regarding short-term risk, PMEDF and NGMDF have similar daily volatility (0.00).
PMEDF vs IRME Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, IRME has a market cap of 5.6M. Regarding current trading prices, PMEDF is priced at $0.01, while IRME trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas IRME's P/E ratio is -2.60. In terms of profitability, PMEDF's ROE is +1.68%, compared to IRME's ROE of +11.77%. Regarding short-term risk, PMEDF is less volatile compared to IRME. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs QLIS Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, QLIS has a market cap of 5.5M. Regarding current trading prices, PMEDF is priced at $0.01, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas QLIS's P/E ratio is 2.22. In terms of profitability, PMEDF's ROE is +1.68%, compared to QLIS's ROE of -1.41%. Regarding short-term risk, PMEDF and QLIS have similar daily volatility (0.00).
PMEDF vs RHNMF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, RHNMF has a market cap of 5.4M. Regarding current trading prices, PMEDF is priced at $0.01, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, PMEDF's ROE is +1.68%, compared to RHNMF's ROE of +15.91%. Regarding short-term risk, PMEDF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs FZMD Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, FZMD has a market cap of 5.2M. Regarding current trading prices, PMEDF is priced at $0.01, while FZMD trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas FZMD's P/E ratio is 1.40. In terms of profitability, PMEDF's ROE is +1.68%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, PMEDF and FZMD have similar daily volatility (0.00).
PMEDF vs TBRIF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, TBRIF has a market cap of 4.9M. Regarding current trading prices, PMEDF is priced at $0.01, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas TBRIF's P/E ratio is -1.08. In terms of profitability, PMEDF's ROE is +1.68%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, PMEDF is less volatile compared to TBRIF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs MICR Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, MICR has a market cap of 4.7M. Regarding current trading prices, PMEDF is priced at $0.01, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas MICR's P/E ratio is -3.47. In terms of profitability, PMEDF's ROE is +1.68%, compared to MICR's ROE of -0.25%. Regarding short-term risk, PMEDF is less volatile compared to MICR. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs BIEL Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, BIEL has a market cap of 4.5M. Regarding current trading prices, PMEDF is priced at $0.01, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas BIEL's P/E ratio is N/A. In terms of profitability, PMEDF's ROE is +1.68%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, PMEDF is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs LBLTF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, LBLTF has a market cap of 4.1M. Regarding current trading prices, PMEDF is priced at $0.01, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, PMEDF's ROE is +1.68%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, PMEDF is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs ADMT Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, ADMT has a market cap of 4M. Regarding current trading prices, PMEDF is priced at $0.01, while ADMT trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas ADMT's P/E ratio is -5.89. In terms of profitability, PMEDF's ROE is +1.68%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, PMEDF and ADMT have similar daily volatility (0.00).
PMEDF vs NUMD Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, NUMD has a market cap of 3.9M. Regarding current trading prices, PMEDF is priced at $0.01, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas NUMD's P/E ratio is 4.70. In terms of profitability, PMEDF's ROE is +1.68%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, PMEDF is less volatile compared to NUMD. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs VYCO Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, VYCO has a market cap of 3.8M. Regarding current trading prices, PMEDF is priced at $0.01, while VYCO trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas VYCO's P/E ratio is -11.50. In terms of profitability, PMEDF's ROE is +1.68%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, PMEDF is less volatile compared to VYCO. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs VANIW Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, VANIW has a market cap of 3.4M. Regarding current trading prices, PMEDF is priced at $0.01, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas VANIW's P/E ratio is N/A. In terms of profitability, PMEDF's ROE is +1.68%, compared to VANIW's ROE of -1.33%. Regarding short-term risk, PMEDF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs ESMC Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, ESMC has a market cap of 2.7M. Regarding current trading prices, PMEDF is priced at $0.01, while ESMC trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas ESMC's P/E ratio is 7.32. In terms of profitability, PMEDF's ROE is +1.68%, compared to ESMC's ROE of +0.00%. Regarding short-term risk, PMEDF is less volatile compared to ESMC. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs USAQ Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, USAQ has a market cap of 2.4M. Regarding current trading prices, PMEDF is priced at $0.01, while USAQ trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas USAQ's P/E ratio is -5.29. In terms of profitability, PMEDF's ROE is +1.68%, compared to USAQ's ROE of +0.67%. Regarding short-term risk, PMEDF is less volatile compared to USAQ. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs CRRVF Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, CRRVF has a market cap of 1.5M. Regarding current trading prices, PMEDF is priced at $0.01, while CRRVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas CRRVF's P/E ratio is -0.01. In terms of profitability, PMEDF's ROE is +1.68%, compared to CRRVF's ROE of +0.00%. Regarding short-term risk, PMEDF is less volatile compared to CRRVF. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.
PMEDF vs KLYG Comparison
PMEDF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PMEDF stands at 2.6M. In comparison, KLYG has a market cap of 1.5M. Regarding current trading prices, PMEDF is priced at $0.01, while KLYG trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PMEDF currently has a P/E ratio of -1.47, whereas KLYG's P/E ratio is -11.96. In terms of profitability, PMEDF's ROE is +1.68%, compared to KLYG's ROE of -1.14%. Regarding short-term risk, PMEDF is less volatile compared to KLYG. This indicates potentially lower risk in terms of short-term price fluctuations for PMEDF.